These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35874165)

  • 1. Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants.
    Yu B; Li S; Tabata T; Wang N; Cao L; Kumar GR; Sun W; Liu J; Ott M; Wang L
    Chem; 2022 Oct; 8(10):2766-2783. PubMed ID: 35874165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating PERx Reaction Enables Covalent Nanobodies for Potent Neutralization of SARS-Cov-2 and Variants.
    Yu B; Li S; Tabata T; Wang N; Kumar GR; Liu J; Ott MM; Wang L
    bioRxiv; 2022 Mar; ():. PubMed ID: 35313590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics.
    Li Q; Chen Q; Klauser PC; Li M; Zheng F; Wang N; Li X; Zhang Q; Fu X; Wang Q; Xu Y; Wang L
    Cell; 2020 Jul; 182(1):85-97.e16. PubMed ID: 32579975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobody engineering for SARS-CoV-2 neutralization and detection.
    Hannula L; Kuivanen S; Lasham J; Kant R; Kareinen L; Bogacheva M; Strandin T; Sironen T; Hepojoki J; Sharma V; Saviranta P; Kipar A; Vapalahti O; Huiskonen JT; Rissanen I
    Microbiol Spectr; 2024 Apr; 12(4):e0419922. PubMed ID: 38363137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529).
    Lu Y; Li Q; Fan H; Liao C; Zhang J; Hu H; Yi H; Peng Y; Lu J; Chen Z
    Int J Nanomedicine; 2023; 18():353-367. PubMed ID: 36700149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proximity-enabled sulfur fluoride exchange reaction in the protein context.
    Yu B; Cao L; Li S; Klauser PC; Wang L
    Chem Sci; 2023 Jul; 14(29):7913-7921. PubMed ID: 37502323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Naïve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern.
    Wu D; Cong J; Wei J; Hu J; Sun W; Ran W; Liao C; Zheng H; Ye L
    Int J Nanomedicine; 2023; 18():5781-5795. PubMed ID: 37869063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1.
    Wang J; Shi B; Chen H; Yu M; Wang P; Qian Z; Hu K; Wang J
    Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant.
    Verkhivker G
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically encoding latent bioreactive amino acids and the development of covalent protein drugs.
    Wang N; Wang L
    Curr Opin Chem Biol; 2022 Feb; 66():102106. PubMed ID: 34968810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Genetically Encoded Fluorosulfonyloxybenzoyl-l-lysine for Expansive Covalent Bonding of Proteins via SuFEx Chemistry.
    Liu J; Cao L; Klauser PC; Cheng R; Berdan VY; Sun W; Wang N; Ghelichkhani F; Yu B; Rozovsky S; Wang L
    J Am Chem Soc; 2021 Jul; 143(27):10341-10351. PubMed ID: 34213894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine Accelerates Sulfur Fluoride Exchange and Phosphorus Fluoride Exchange Reactions between Proteins.
    Cao L; Yu B; Klauser PC; Zhang P; Li S; Wang L
    Angew Chem Int Ed Engl; 2024 Nov; 63(47):e202412843. PubMed ID: 39113386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters.
    Aksu M; Kumar P; Güttler T; Taxer W; Gregor K; Mußil B; Rymarenko O; Stegmann KM; Dickmanns A; Gerber S; Reineking W; Schulz C; Henneck T; Mohamed A; Pohlmann G; Ramazanoglu M; Mese K; Groß U; Ben-Yedidia T; Ovadia O; Fischer DW; Kamensky M; Reichman A; Baumgärtner W; von Köckritz-Blickwede M; Dobbelstein M; Görlich D
    Antiviral Res; 2024 Jan; 221():105778. PubMed ID: 38065245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
    Ye G; Pan R; Bu F; Zheng J; Mendoza A; Wen W; Du L; Spiller B; Wadzinski BE; Liu B; Perlman S; Li F
    J Virol; 2023 Nov; 97(11):e0144823. PubMed ID: 37855638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice.
    Nagata K; Utsumi D; Asaka MN; Maeda R; Shirakawa K; Kazuma Y; Nomura R; Horisawa Y; Yanagida Y; Kawai Y; Sato K; Yamaoka Y; Miyakawa K; Ryo A; Yasutomi Y; Imura A; Takaori-Kondo A
    Commun Med (Lond); 2022 Nov; 2(1):152. PubMed ID: 36435945
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhu X; An K; Yan J; Xu P; Bai C
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):67. PubMed ID: 37114534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization.
    Zhang R; Huang L; Zhang X; Yu Y; Liang T; Wang H; Zhang X; Hu D; Wang B; Wang Y; Jiang J; Yu X
    J Proteome Res; 2024 May; 23(5):1559-1570. PubMed ID: 38603467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization.
    Yang J; Lin S; Chen Z; Yang F; Guo L; Wang L; Duan Y; Zhang X; Dai Y; Yin K; Yu C; Yuan X; Sun H; He B; Cao Y; Ye H; Dong H; Liu X; Chen B; Li J; Zhao Q; Lu G
    PLoS Pathog; 2023 Nov; 19(11):e1011804. PubMed ID: 38033141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure basis of two nanobodies neutralizing SARS-CoV-2 Omicron variant by targeting ultra-conservative epitopes.
    Sun Z; Wang L; Li L; Sun Y; Zhang D; Zhou S; Li Y; Li X; Qiao H; Cui Q; Lan Z; Meng X; Xu J; Geng Y; Dai Y
    J Struct Biol; 2023 Sep; 215(3):107996. PubMed ID: 37419228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2.
    Cornish K; Huo J; Jones L; Sharma P; Thrush JW; Abdelkarim S; Kipar A; Ramadurai S; Weckener M; Mikolajek H; Liu S; Buckle I; Bentley E; Kirby A; Han X; Laidlaw SM; Hill M; Eyssen L; Norman C; Le Bas A; Clarke J; James W; Stewart JP; Carroll M; Naismith JH; Owens RJ
    Open Biol; 2024 Jun; 14(6):230252. PubMed ID: 38835241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.